SCHEMBL8510266

SCHEMBL8510266

Cc1nc(-c2ccc3ccccc3c2)n(-c2ccccc2C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.44
ALDH1A1 P00352 5/20 0.43
MAPT P10636 2/20 0.43
TSHR P16473 2/20 0.39
POLB P06746 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
HTT P42858 2/20 0.38
HSD11B1 P28845 1/20 0.37
CYP2C19 P33261 1/20 0.37
RAB9A P51151 1/20 0.37
IKBKB O14920 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29533750 0.82 ALDH1A1 (0.56) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL461814 0.82 ALDH1A1 (0.56) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL27941915 0.82 AKT1 (0.40) AKT1ALDH1A1MAPTTSHRCYP1A2
SCHEMBL29462009 0.81 ALDH1A1 (0.54) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL28868616 0.81 ALDH1A1 (0.54) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL30317717 0.81 ALDH1A1 (0.54) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL16642051 0.78 TDP2 (0.43) AKT1ALDH1A1MAPTTSHRCYP1A2
SCHEMBL18118494 0.73 AKT1 (0.44) AKT1ALDH1A1MAPTTSHRPOLB
SCHEMBL14118610 0.72 TDP2 (0.39) AKT1ALDH1A1MAPTTSHRCYP1A2
SCHEMBL13921749 0.71 CA12 (0.41) AKT1ALDH1A1MAPTSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120133273-A1 Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-31 US disclosed
WO-2012070596-A1 ORGANOMETALLIC COMPLEX, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-31 WO disclosed
US-20120133273-A1 Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-31 US disclosed
US-20120133273-A1 Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-31 US disclosed
WO-2012070596-A1 ORGANOMETALLIC COMPLEX, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120133273-A1 Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device LAGE3, CRY1, CYBA AKT1 4629/4885ALDH1A1 379/4885MAPT 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.